Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,519 | -34,336 | -32,761 | -154,761 | -185,111 |
| Depreciation Amortization | 14,881 | 22,489 | 29,028 | 33,509 | 24,377 |
| Accounts receivable | 6,034 | 10,476 | 24,318 | -34,654 | 2,468 |
| Accounts payable and accrued liabilities | -8,046 | 6,181 | -3,147 | -8,926 | 9,009 |
| Other Working Capital | 117,708 | -26,794 | 106,751 | -8,852 | 4,591 |
| Other Operating Activity | 11,681 | -123,798 | 22,113 | 80,969 | 66,668 |
| Operating Cash Flow | $39,739 | $-145,782 | $146,302 | $-92,715 | $-77,998 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 405,622 | N/A |
| PPE Investments | -20,702 | -18,855 | -32,796 | -22,524 | -17,955 |
| Net Acquisitions | -4,440 | 114,831 | N/A | N/A | -30,714 |
| Purchase Of Investment | -451,918 | -479,552 | -593,118 | -502,230 | -234,991 |
| Sale Of Investment | 328,025 | 658,228 | 593,259 | 2,252 | 316,063 |
| Investing Cash Flow | $-149,035 | $274,652 | $-32,655 | $-116,880 | $32,403 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 305,906 |
| Debt Repayment | -1,285 | -50,125 | -2,895 | -10,488 | -73,481 |
| Common Stock Issued | 4,820 | 384 | 3,780 | 22,259 | 42,424 |
| Other Financing Activity | 0 | 0 | -102,653 | 0 | 0 |
| Financing Cash Flow | $3,535 | $-49,741 | $-101,768 | $11,771 | $274,849 |
| Exchange Rate Effect | -226 | 162 | 654 | 311 | -45 |
| Beginning Cash Position | 155,584 | 76,293 | 63,760 | 261,273 | 32,064 |
| End Cash Position | 49,597 | 155,584 | 76,293 | 63,760 | 261,273 |
| Net Cash Flow | $-105,987 | $79,291 | $12,533 | $-197,513 | $229,209 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,739 | -145,782 | 146,302 | -92,715 | -77,998 |
| Capital Expenditure | -20,702 | -18,855 | -32,796 | -22,524 | -17,955 |
| Free Cash Flow | 19,037 | -164,637 | 113,506 | -115,239 | -95,953 |